Notably, molecules like Programmed Cell Death Protein 1 (PD-1), Cytotoxic T-lymphocyte associated protein 4 (CTLA4), and their ligands have emerged as focal points for anti-cancer immunotherapy, while other checkpoint pathways contribute to the immunopathogenesis of human diseases as critically analyzed by Riva A (19). Here, PDCD1 is linked to cancer.